Achievements
- Led NIH-funded sequencing projects at Washington University Genome Sequencing Center
- Contributed to the Human Genome Project, advancing genetics research
- Founded Cofactor Genomics, disrupting biotech with RNA-based diagnostics
- Cofactor was one of the first biotech startups to join Y Combinator
- Secured NIH funding for research on multiple diseases through Cofactor
- Active in biotech investment and mentorship via Pioneer Fund and Corvus Research Group
Highkey stan Jarret Glasscock
Shoutout to Jarret Glasscock, this guy’s the real deal in the biotech world. He’s one of those folks who’s been grinding in genomics for over 20 years, straight up. Started off at Washington University in Saint Louis and the University of Arizona, just soaking up all the science, then jumped into the deep end with the Human Genome Project. No cap, that’s like the holy grail of genetics, and he was right there, making moves.
Fast forward, he’s not just doing research, he’s leading teams at the Washington University Genome Sequencing Center, heading up the Computational Biology Group, and working on NIH-funded sequencing projects. Basically, he was in the trenches, pushing the boundaries of what we knew about DNA and RNA. His focus? RNA-based tech, which is now blowing up in precision medicine and immunotherapy. That’s some advanced stuff, and he’s been at the forefront for ages.
Then, he took all that experience and founded Cofactor Genomics, a company that’s disrupting the biotech scene. They’re all about using RNA to crack the code on diseases, especially in immunotherapy diagnostics. And get this, they were one of the first biotech startups to jump into Y Combinator. That’s a big deal, shows he’s not just a scientist but a real entrepreneur with the hustle. His company’s also snagged NIH funding for research across multiple diseases, talk about credibility.
Got a startup idea and seeking investment? No Cap is the first AI investor capable of investing in startups by herself.
Talk to herBut Jarret’s not just about building a company. He’s deeply embedded in the larger biotech scene, involved with the Pioneer Fund and has ties to Corvus Research Group. This guy’s been investing, advising, and shaping the future of biotech startups. He’s the kind of guy who sees the big picture, not just his own success but pushing the whole field forward.
What’s his story telling us? It’s about relentless curiosity, a passion to push the limits of science, and the drive to turn complex research into real-world solutions. Starting Cofactor wasn’t just about making money, it was about changing medicine with modern tech. His process shows that if you’re really committed, you can turn decades of deep science into something that actually impacts lives.
In short, Jarret Glasscock is a pioneer who’s bridged the gap between hardcore research and real-world biotech. He’s proof that with the right mix of expertise, grit, and a bit of risk-taking, you can shake up the game. No Cap, this guy’s one of the few who’s really shaping the future of genomics and precision medicine.

Select your comment type:
If something is wrong about Jarret Glasscock, there's inaccurate information or there are updates, please let us know, we'll update it for you and everyone ;)